Cardiac shock-wave therapy in the treatment of refractive angina pectoris

Juan Ruiz-Garcia, Amir Lerman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

An increasing number of patients are being diagnosed with severe coronary artery disease not amenable to traditional revascularization. Most of them remain symptomatic despite optimal medical therapy, so the resulting qualiy of life is poor. Thus, there is a need for the development of novel therapies. Shock waves (SWs) have been used in medicine for 30 years, but the recent discovery of their potential angiogenic effect has led to their most promising application in cardiovascular medicine. Cardiac SW therapy delivered to ischemic myocardium has been demonstrated to reduce angina symptoms and to improve myocardial perfusion. And although there is a lack of large series and long-term follow-up, cardiac SW therapy is by now a safe, well-tolerated procedure with no significant side effects.

Original languageEnglish (US)
Pages (from-to)191-201
Number of pages11
JournalInterventional Cardiology
Volume3
Issue number2
DOIs
StatePublished - Apr 2011

Fingerprint

Convulsive Therapy
Angina Pectoris
Medicine
Coronary Artery Disease
Myocardium
Perfusion
Therapeutics

Keywords

  • advanced coronary disease
  • angiogenesis
  • extracorporeal shock-wave therapy
  • nonrevascularizable patient

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac shock-wave therapy in the treatment of refractive angina pectoris. / Ruiz-Garcia, Juan; Lerman, Amir.

In: Interventional Cardiology, Vol. 3, No. 2, 04.2011, p. 191-201.

Research output: Contribution to journalArticle

@article{168d70b5453d48fab92a56f48d783b4c,
title = "Cardiac shock-wave therapy in the treatment of refractive angina pectoris",
abstract = "An increasing number of patients are being diagnosed with severe coronary artery disease not amenable to traditional revascularization. Most of them remain symptomatic despite optimal medical therapy, so the resulting qualiy of life is poor. Thus, there is a need for the development of novel therapies. Shock waves (SWs) have been used in medicine for 30 years, but the recent discovery of their potential angiogenic effect has led to their most promising application in cardiovascular medicine. Cardiac SW therapy delivered to ischemic myocardium has been demonstrated to reduce angina symptoms and to improve myocardial perfusion. And although there is a lack of large series and long-term follow-up, cardiac SW therapy is by now a safe, well-tolerated procedure with no significant side effects.",
keywords = "advanced coronary disease, angiogenesis, extracorporeal shock-wave therapy, nonrevascularizable patient",
author = "Juan Ruiz-Garcia and Amir Lerman",
year = "2011",
month = "4",
doi = "10.2217/ica.11.5",
language = "English (US)",
volume = "3",
pages = "191--201",
journal = "Interventional Cardiology (London)",
issn = "1755-5302",
publisher = "Future Medicine Ltd.",
number = "2",

}

TY - JOUR

T1 - Cardiac shock-wave therapy in the treatment of refractive angina pectoris

AU - Ruiz-Garcia, Juan

AU - Lerman, Amir

PY - 2011/4

Y1 - 2011/4

N2 - An increasing number of patients are being diagnosed with severe coronary artery disease not amenable to traditional revascularization. Most of them remain symptomatic despite optimal medical therapy, so the resulting qualiy of life is poor. Thus, there is a need for the development of novel therapies. Shock waves (SWs) have been used in medicine for 30 years, but the recent discovery of their potential angiogenic effect has led to their most promising application in cardiovascular medicine. Cardiac SW therapy delivered to ischemic myocardium has been demonstrated to reduce angina symptoms and to improve myocardial perfusion. And although there is a lack of large series and long-term follow-up, cardiac SW therapy is by now a safe, well-tolerated procedure with no significant side effects.

AB - An increasing number of patients are being diagnosed with severe coronary artery disease not amenable to traditional revascularization. Most of them remain symptomatic despite optimal medical therapy, so the resulting qualiy of life is poor. Thus, there is a need for the development of novel therapies. Shock waves (SWs) have been used in medicine for 30 years, but the recent discovery of their potential angiogenic effect has led to their most promising application in cardiovascular medicine. Cardiac SW therapy delivered to ischemic myocardium has been demonstrated to reduce angina symptoms and to improve myocardial perfusion. And although there is a lack of large series and long-term follow-up, cardiac SW therapy is by now a safe, well-tolerated procedure with no significant side effects.

KW - advanced coronary disease

KW - angiogenesis

KW - extracorporeal shock-wave therapy

KW - nonrevascularizable patient

UR - http://www.scopus.com/inward/record.url?scp=79955749015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955749015&partnerID=8YFLogxK

U2 - 10.2217/ica.11.5

DO - 10.2217/ica.11.5

M3 - Article

VL - 3

SP - 191

EP - 201

JO - Interventional Cardiology (London)

JF - Interventional Cardiology (London)

SN - 1755-5302

IS - 2

ER -